Report: Medtronic to invest $70 million in Israeli heart firm

May 24, 2010 by MedCity News

Medtronic Inc. plans to invest $70 million in neurostimulation device maker BioControl Medical Ltd., according to a report from an Israeli media outlet.

MedCity News logo

By Brandon Glenn

Medtronic Inc. (NYSE:MDT) plans to invest $70 million in neurostimulation device maker BioControl Medical Ltd., according to a report from an Israeli media outlet.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp